Your browser doesn't support javascript.
loading
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
Casey, Nicholas Paul; Klee, Clara Helena; Fåne, Anne; Caulier, Benjamin; Graczyk-Jarzynka, Agnieszka; Krawczyk, Marta; Fidyt, Klaudyna; Josefsson, Sarah E; Köksal, Hakan; Dillard, Pierre; Patkowska, Elzbieta; Firczuk, Malgorzata; Smeland, Erlend B; Winiarska, Magdalena; Myklebust, June H; Inderberg, Else Marit; Wälchli, Sébastien.
Affiliation
  • Casey NP; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Klee CH; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Fåne A; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Caulier B; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Center for Cancer Cell Reprogramming (CanCell), Institute for Clinical Medicine, University of Oslo, Oslo, Norway; Department of Molecular Cell Biology, Inst
  • Graczyk-Jarzynka A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
  • Krawczyk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
  • Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
  • Josefsson SE; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Köksal H; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Dillard P; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Patkowska E; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
  • Firczuk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
  • Smeland EB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Winiarska M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.
  • Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Inderberg EM; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: elsmar@rr-research.no.
  • Wälchli S; Translational Research Unit, Section of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: sebastw@rr-research.no.
J Biol Chem ; 299(7): 104883, 2023 07.
Article in En | MEDLINE | ID: mdl-37269947
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sialic Acid Binding Ig-like Lectin 2 / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: J Biol Chem Year: 2023 Document type: Article Affiliation country: Norway Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sialic Acid Binding Ig-like Lectin 2 / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: J Biol Chem Year: 2023 Document type: Article Affiliation country: Norway Country of publication: United States